as per annexure enclosed
Awaiting price reaction for this filing.
Apollo Hospitals reported strong FY25 results with consolidated revenue from operations rising ~14.4% to Rs 21,794 crore (vs Rs 19,059 crore in FY24). Consolidated PAT jumped ~61% to Rs 1,505 crore (vs Rs 935 crore), and consolidated EPS rose to Rs 100.56 from Rs 62.50. On a standalone basis, revenue grew ~12.8% to Rs 8,202 crore, PAT grew ~28.3% to Rs 1,296 crore, and EBITDA stood at Rs 2,044 crore. The Board recommended a final dividend of Rs 10/share (200%) taking total FY25 dividend to Rs 19/share (380%), totaling Rs 273 crore. Additional business items include a Rs 285 crore proposal to acquire an existing 200-bed hospital, re-appointment of executive directors, and reaffirmation of AA+/Stable credit ratings by CRISIL and India Ratings.
Strong double-digit revenue growth and over 25% PAT growth, combined with a healthy total dividend of 380%, signal robust operational performance and shareholder returns. The clean (unmodified) audit opinion and stable AA+ credit rating reinforce investor confidence, while the hospital acquisition signals continued expansion capacity.